The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
Therapeutic potential of β-arrestin- and G protein-biased agonists
Open accessAbstract
Members of the seven-transmembrane receptor (7TMR), or G protein-coupled receptor (GPCR), superfamily represent some of the most successful targets of modern drug therapy, with proven efficacy in the treatment of a broad range of human conditions and disease processes. It is now appreciated that β-arrestins, once viewed simply as negative regulators of traditional 7TMR-stimulated G protein signaling, act as multifunctional adapter proteins that regulate 7TMR desensitization and trafficking and promote distinct intracellular signals in their own right. Moreover, several 7TMR biased agonists, which selectively activate these divergent signaling pathways, have been identified. Here we highlight the diversity of G protein- and β-arrestin-mediated functions and the therapeutic potential of selective targeting of these in disease states.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111303 · Cited by 3,125
Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,886
Pierce, K. L., Premont, R. T., & Lefkowitz, R. J. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm908 · Cited by 2,701
Self-citationStructural diversity of G protein-coupled receptors and significance for drug discovery
Lagerström, M. C., & Schiöth, H. B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2518 · Cited by 1,492
β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F.-T., Kawakatsu, H., Owada, K., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,475
Self-citationβ-Arrestins and Cell Signaling
DeWire, S. M., Ahn, S., Lefkowitz, R. J., & Shenoy, S. K. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154749 · Cited by 1,397
Self-citationβ-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor
Goodman, O. B., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W., Keen, J. H., & Benovic, J. L. (1996) · Nature · doi:10.1038/383447a0 · Cited by 1,384
G PROTEIN–COUPLED RECEPTOR KINASES
Pitcher, J. A., Freedman, N. J., & Lefkowitz, R. J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.653 · Cited by 1,361
Self-citationβ-Arrestin: a Protein that Regulates β-adrenergic Receptor Function
Lohse, M. J., Benovic, J. L., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1990) · Science · doi:10.1126/science.2163110 · Cited by 1,220
Self-citationFunctional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
Bohn, L. M., Lefkowitz, R. J., Gainetdinov, R. R., Peppel, K., Caron, M. G., & Lin, F.-T. (1999) · Science · doi:10.1126/science.286.5449.2495 · Cited by 1,077
Self-citationβ-Adrenergic Receptor Blockade in Chronic Heart Failure
Bristow, M. R. (2000) · Circulation · doi:10.1161/01.cir.101.5.558 · Cited by 1,028
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
Beaulieu, J.-M., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 980
Self-citationμ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
Bohn, L. M., Gainetdinov, R. R., Lin, F.-T., Lefkowitz, R. J., & Caron, M. G. (2000) · Nature · doi:10.1038/35047086 · Cited by 927
Self-citationDESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
Gainetdinov, R. R., Premont, R. T., Bohn, L. M., Lefkowitz, R. J., & Caron, M. G. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144206 · Cited by 860
Self-citationTeaching old receptors new tricks: biasing seven-transmembrane receptors
Rajagopal, S., Rajagopal, K., & Lefkowitz, R. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3024 · Cited by 825
Self-citationRegulation of Receptor Fate by Ubiquitination of Activated β 2 -Adrenergic Receptor and β-Arrestin
Shenoy, S. K., McDonald, P. H., Kohout, T. A., & Lefkowitz, R. J. (2001) · Science · doi:10.1126/science.1063866 · Cited by 824
Self-citationDeFea, K. A., Zalevsky, J., Thoma, M. S., Déry, O., Mullins, R. D., & Bunnett, N. W. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.6.1267 · Cited by 822
What Is the Role of β-Adrenergic Signaling in Heart Failure?
Lohse, M. J., Engelhardt, S., & Eschenhagen, T. (2003) · Circulation Research · doi:10.1161/01.res.0000102042.83024.ca · Cited by 764
Wei, H., Ahn, S., Shenoy, S. K., Karnik, S. S., Hunyady, L., Luttrell, L. M., & Lefkowitz, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834556100 · Cited by 690
Self-citationThe β 2 -adrenergic receptor/βarrestin complex recruits the clathrin adaptor AP-2 during endocytosis
Laporte, S. A., Oakley, R. H., Zhang, J., Holt, J. A., Ferguson, S. S. G., Caron, M. G., & Barak, L. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3712 · Cited by 635
Morphine Side Effects in β-Arrestin 2 Knockout Mice
Raehal, K. M., Walker, J. K. L., & Bohn, L. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087254 · Cited by 626
β-Arrestin-biased ligands at seven-transmembrane receptors
Violin, J. D., & Lefkowitz, R. J. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.006 · Cited by 606
Self-citationA unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K., & Lefkowitz, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707936104 · Cited by 597
Self-citationKenakin, T., & Miller, L. J. (2010) · Pharmacological Reviews · doi:10.1124/pr.108.000992 · Cited by 573
The immunosuppressant FTY720 down‐regulates sphingosine 1‐phosphate G protein‐coupled receptors
Gräler, M. H., & Goetzl, E. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-0910fje · Cited by 539
Azzi, M., Charest, P. G., Angers, S., Rousseau, G., Kohout, T., Bouvier, M., & Piñeyro, G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1936664100 · Cited by 523
Berg, K. A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P., & Clarke, W. P. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.94 · Cited by 510
Ahn, S., Shenoy, S. K., Wei, H., & Lefkowitz, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405878200 · Cited by 508
Self-citationTargeting of Cyclic AMP Degradation to β 2 -Adrenergic Receptors by β-Arrestins
Perry, S. J., Baillie, G. S., Kohout, T. A., McPhee, I., Magiera, M. M., Ang, K. L., Miller, W. E., McLean, A. J., Conti, M., Houslay, M. D., et al. (2002) · Science · doi:10.1126/science.1074683 · Cited by 506
Self-citationZhang, J., Ferguson, S. S. G., Barak, L. S., Bodduluri, S. R., Laporte, S. A., Law, P.-Y., & Caron, M. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.7157 · Cited by 505
Gesty-Palmer, D., Chen, M., Reiter, E., Ahn, S., Nelson, C. D., Wang, S., Eckhardt, A. E., Cowan, C. L., Spurney, R. F., Luttrell, L. M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513380200 · Cited by 476
Self-citationJohnson, A. K., & Thunhorst, R. L. (1997) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1997.0153 · Cited by 464
Oakley, R. H., Laporte, S. A., Holt, J. A., Barak, L. S., & Caron, M. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101450200 · Cited by 455
Functional specialization of β-arrestin interactions revealed by proteomic analysis
Xiao, K., McClatchy, D. B., Shukla, A. K., Zhao, Y., Chen, M., Shenoy, S. K., Yates, J. R., & Lefkowitz, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704849104 · Cited by 420
Self-citationβ-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
Noma, T., Lemaire, A., Naga Prasad, S. V., Barki-Harrington, L., Tilley, D. G., Chen, J., Le Corvoisier, P., Violin, J. D., Wei, H., Lefkowitz, R. J., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31901 · Cited by 418
Self-citationInverse, protean, and ligand‐selective agonism: matters of receptor conformation
KENAKIN, T. (2001) · The FASEB Journal · doi:10.1096/fj.00-0438rev · Cited by 408
Mack, M., Luckow, B., Nelson, P. J., Cihak, J., Simmons, G., Clapham, P. R., Signoret, N., Marsh, M., Stangassinger, M., Borlat, F., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1215 · Cited by 405
DeFea, K. A., Vaughn, Z. D., O'Bryan, E. M., Nishijima, D., Déry, O., & Bunnett, N. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190276697 · Cited by 405
Gq‐coupled receptors as mechanosensors mediating myogenic vasoconstriction
Mederos y Schnitzler, M., Storch, U., Meibers, S., Nurwakagari, P., Breit, A., Essin, K., Gollasch, M., & Gudermann, T. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.233 · Cited by 382
Chemokine receptor CCR5: insights into structure, function, and regulation
Oppermann, M. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.04.007 · Cited by 376
Morphine-activated opioid receptors elude desensitization by β-arrestin
Whistler, J. L., & von Zastrow, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9914 · Cited by 370
Violin, J. D., DeWire, S. M., Yamashita, D., Rominger, D. H., Nguyen, L., Schiller, K., Whalen, E. J., Gowen, M., & Lark, M. W. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173005 · Cited by 370
Self-citationBeyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling
Luttrell, L. M., Gesty-Palmer, D., & Sibley, D. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002436 · Cited by 369
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
Beaulieu, J.-M., Marion, S., Rodriguiz, R. M., Medvedev, I. O., Sotnikova, T. D., Ghisi, V., Wetsel, W. C., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2008) · Cell · doi:10.1016/j.cell.2007.11.041 · Cited by 362
Self-citationMast Cell Tryptase Controls Paracellular Permeability of the Intestine
Jacob, C., Yang, P.-C., Darmoul, D., Amadesi, S., Saito, T., Cottrell, G. S., Coelho, A.-M., Singh, P., Grady, E. F., Perdue, M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506338200 · Cited by 334
Kohout, T. A., Nicholas, S. L., Perry, S. J., Reinhart, G., Junger, S., & Struthers, R. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402125200 · Cited by 333
Balabanian, K. (2005) · Blood · doi:10.1182/blood-2004-06-2289 · Cited by 322
Rimondini, R., Arlinde, C., Sommer, W., & Heilig, M. (2002) · The FASEB Journal · doi:10.1096/fj.01-0593com · Cited by 321
Masri, B., Salahpour, A., Didriksen, M., Ghisi, V., Beaulieu, J.-M., Gainetdinov, R. R., & Caron, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803522105 · Cited by 320
New Concepts in Drug Discovery: Collateral Efficacy and Permissive Antagonism
Kenakin, T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1875 · Cited by 317
Defective lymphocyte chemotaxis in β-arrestin2- and GRK6-deficient mice
Fong, A. M., Premont, R. T., Richardson, R. M., Yu, Y.-R. A., Lefkowitz, R. J., & Patel, D. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112198299 · Cited by 311
Self-citationNicotine induces cell proliferation by -arrestin-mediated activation of Src and Rb-Raf-1 pathways
Dasgupta, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28164 · Cited by 311
Ma, L., Seager, M. A., Wittmann, M., Jacobson, M., Bickel, D., Burno, M., Jones, K., Graufelds, V. K., Xu, G., Pearson, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900903106 · Cited by 285
Stress-Induced p38 Mitogen-Activated Protein Kinase Activation Mediates κ-Opioid-Dependent Dysphoria
Bruchas, M. R., Land, B. B., Aita, M., Xu, M., Barot, S. K., Li, S., & Chavkin, C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3769-07.2007 · Cited by 281
Zidar, D. A., Violin, J. D., Whalen, E. J., & Lefkowitz, R. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904361106 · Cited by 278
Self-citationβ-Blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivation
Kim, I.-M., Tilley, D. G., Chen, J., Salazar, N. C., Whalen, E. J., Violin, J. D., & Rockman, H. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804745105 · Cited by 276
Self-citationRole of β-arrestin 1 in the metastatic progression of colorectal cancer
Buchanan, F. G., Gorden, D. L., Matta, P., Shi, Q., Matrisian, L. M., & DuBois, R. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510562103 · Cited by 267
Xiao, R.-P. (2001) · Science's STKE · doi:10.1126/stke.2001.104.re15 · Cited by 264
Bruchas, M. R., Macey, T. A., Lowe, J. D., & Chavkin, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513640200 · Cited by 258
β-Arrestin-biased Agonism at the β2-Adrenergic Receptor
Drake, M. T., Violin, J. D., Whalen, E. J., Wisler, J. W., Shenoy, S. K., & Lefkowitz, R. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708118200 · Cited by 254
Self-citationBarak, L. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011303698 · Cited by 249
β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
Walters, R. W., Shukla, A. K., Kovacs, J. J., Violin, J. D., DeWire, S. M., Lam, C. M., Chen, J. R., Muehlbauer, M. J., Whalen, E. J., & Lefkowitz, R. J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36806 · Cited by 240
Self-citationSonoda, N., Imamura, T., Yoshizaki, T., Babendure, J. L., Lu, J.-C., & Olefsky, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710402105 · Cited by 239
Ahn, S., Nelson, C. D., Garrison, T. R., Miller, W. E., & Lefkowitz, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262789099 · Cited by 239
Self-citationAgonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivo
Schmid, C. L., Raehal, K. M., & Bohn, L. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708862105 · Cited by 229
Wang, Y., Tang, Y., Teng, L., Wu, Y., Zhao, X., & Pei, G. (2006) · Nature Immunology · doi:10.1038/ni1294 · Cited by 228
Sears, M. R. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.129966 · Cited by 223
Koole, C., Wootten, D., Simms, J., Valant, C., Sridhar, R., Woodman, O. L., Miller, L. J., Summers, R. J., Christopoulos, A., & Sexton, P. M. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065664 · Cited by 223
μ Opioid Receptor Phosphorylation, Desensitization, and Ligand Efficacy
Yu, Y., Zhang, L., Yin, X., Sun, H., Uhl, G. R., & Wang, J. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.28869 · Cited by 219
Deficiency of a β-arrestin-2 signal complex contributes to insulin resistance
Luan, B., Zhao, J., Wu, H., Duan, B., Shu, G., Wang, X., Li, D., Jia, W., Kang, J., & Pei, G. (2009) · Nature · doi:10.1038/nature07617 · Cited by 217
Loss of myometrial oxytocin receptors during oxytocin-induced and oxytocin-augmented labour
Phaneuf, S., Rodriguez Linares, B., TambyRaja, R., MacKenzie, I., & Lopez Bernal, A. (2000) · Reproduction · doi:10.1530/jrf.0.1200091 · Cited by 216
Rajagopal, K., Whalen, E. J., Violin, J. D., Stiber, J. A., Rosenberg, P. B., Premont, R. T., Coffman, T. M., Rockman, H. A., & Lefkowitz, R. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607583103 · Cited by 214
Self-citationEnhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice
Bohn, L. M., Gainetdinov, R. R., Sotnikova, T. D., Medvedev, I. O., Lefkowitz, R. J., Dykstra, L. A., & Caron, M. G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10265.2003 · Cited by 210
Self-citationConner, D. A., Mathier, M. A., Mortensen, R. M., Christe, M., Vatner, S. F., Seidman, C. E., & Seidman, J. G. (1997) · Circulation Research · doi:10.1161/01.res.81.6.1021 · Cited by 207
Gesty-Palmer, D., Flannery, P., Yuan, L., Corsino, L., Spurney, R., Lefkowitz, R. J., & Luttrell, L. M. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000071 · Cited by 205
Self-citationβ-Arrestin-2 regulates the development of allergic asthma
Walker, J. K. L., Fong, A. M., Lawson, B. L., Savov, J. D., Patel, D. D., Schwartz, D. A., & Lefkowitz, R. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17265 · Cited by 198
Self-citationXiao, K., Sun, J., Kim, J., Rajagopal, S., Zhai, B., Villén, J., Haas, W., Kovacs, J. J., Shukla, A. K., Hara, M. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008461107 · Cited by 197
Self-citationBhandari, D., Trejo, J., Benovic, J. L., & Marchese, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705085200 · Cited by 196
Barnes, W. G., Reiter, E., Violin, J. D., Ren, X.-R., Milligan, G., & Lefkowitz, R. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412924200 · Cited by 194
Self-citationShenoy, S. K., Xiao, K., Venkataramanan, V., Snyder, P. M., Freedman, N. J., & Weissman, A. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709668200 · Cited by 193
Endocytosis and Recycling of the HIV Coreceptor Ccr5
Signoret, N., Pelchen-Matthews, A., Mack, M., Proudfoot, A. E. I., & Marsh, M. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.6.1281 · Cited by 189
Quoyer, J., Longuet, C., Broca, C., Linck, N., Costes, S., Varin, E., Bockaert, J., Bertrand, G., & Dalle, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.067207 · Cited by 187
β-Arrestin–Biased Agonism of the Angiotensin Receptor Induced by Mechanical Stress
Rakesh, K., Yoo, B., Kim, I.-M., Salazar, N., Kim, K.-S., & Rockman, H. A. (2010) · Science Signaling · doi:10.1126/scisignal.2000769 · Cited by 186
Bruchas, M. R., Yang, T., Schreiber, S., DeFino, M., Kwan, S. C., Li, S., & Chavkin, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705540200 · Cited by 183
Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.
Cescato, R., Schulz, S., Waser, B., Eltschinger, V., Rivier, J., Wester, H.-J., Culler, M. D., Ginj, M., Liu, Q., Schönbrunn, A., et al. (2006) · PubMed · Cited by 183
Ahn, S., Wei, H., Garrison, T. R., & Lefkowitz, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300443200 · Cited by 177
Self-citationMa, P., & Zemmel, R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd884 · Cited by 174
Lesche, S., Lehmann, D., Nagel, F., Schmid, H. A., & Schulz, S. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1919 · Cited by 172
Willins, D. L., Berry, S. A., Alsayegh, L., Backstrom, J. R., Sanders-Bush, E., Friedman, L., & Roth, B. L. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00653-8 · Cited by 171
Zhai, P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25330 · Cited by 171
Bohn, L. M., Dykstra, L. A., Lefkowitz, R. J., Caron, M. G., & Barak, L. S. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.106 · Cited by 171
Self-citationShenoy, S. K., Modi, A. S., Shukla, A. K., Xiao, K., Berthouze, M., Ahn, S., Wilkinson, K. D., Miller, W. E., & Lefkowitz, R. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901083106 · Cited by 167
Self-citationKurrasch-Orbaugh, D. M., Watts, V. J., Barker, E. L., & Nichols, D. E. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042184 · Cited by 166
The deubiquitinases USP33 and USP20 coordinate β2 adrenergic receptor recycling and resensitization
Berthouze, M., Venkataramanan, V., Li, Y., & Shenoy, S. K. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.128 · Cited by 165
Rosanò, L., Cianfrocca, R., Masi, S., Spinella, F., Di Castro, V., Biroccio, A., Salvati, E., Nicotra, M. R., Natali, P. G., & Bagnato, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807158106 · Cited by 164
Bhatnagar, A., Willins, D. L., Gray, J. A., Woods, J., Benovic, J. L., & Roth, B. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006968200 · Cited by 163
Oxytocin-induced desensitization of the oxytocin receptor
Robinson, C., Schumann, R., Zhang, P., & Young, R. C. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.22 · Cited by 162
Mythreye, K., & Blobe, G. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812879106 · Cited by 162
Hartley, O., Gaertner, H., Wilken, J., Thompson, D. A., Fish, R., Ramos, A. G., Pastore, C., Dufour, B., Cerini, F., Melotti, A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404802101 · Cited by 160
Gregory, K. J., Hall, N. E., Tobin, A. B., Sexton, P. M., & Christopoulos, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094011 · Cited by 159
β-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation
Ahn, S., Kim, J., Hara, M. R., Ren, X.-R., & Lefkowitz, R. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808463200 · Cited by 159
Self-citationChristensen, G. L., Kelstrup, C. D., Lyngsø, C., Sarwar, U., Bøgebo, R., Sheikh, S. P., Gammeltoft, S., Olsen, J. V., & Hansen, J. L. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900550-mcp200 · Cited by 156
Poulin, B., Butcher, A. J., McWilliams, P., Bourgognon, J.-M., Pawlak, R., Kong, K. C., Bottrill, A. R., Mistry, S. C., Wess, J., Rosethorne, E. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914801107 · Cited by 156
Bernier, V., Lagacé, M., Lonergan, M., Arthus, M., Bichet, D. G., & Bouvier, M. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0080 · Cited by 154
Spinophilin Blocks Arrestin Actions in Vitro and in Vivo at G Protein-Coupled Receptors
Wang, Q., Zhao, J., Brady, A. E., et al. (2004) · Science · doi:10.1126/science.1098274 · Cited by 151
Blanpain, C., Vanderwinden, J., Cihak, J., Wittamer, V., Poul, E. L., Issafras, H., Stangassinger, M., Vassart, G., Marullo, S., Schlöndorff, D., et al. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-03-0129 · Cited by 151
Li, T. T., Alemayehu, M., Aziziyeh, A. I., Pape, C., Pampillo, M., Postovit, L.-M. M., Mills, G. B., Babwah, A. V., & Bhattacharya, M. M. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0578 · Cited by 149
Ubiquitination of β-Arrestin Links Seven-transmembrane Receptor Endocytosis and ERK Activation
Shenoy, S. K., Barak, L. S., Xiao, K., Ahn, S., Berthouze, M., Shukla, A. K., Luttrell, L. M., & Lefkowitz, R. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700852200 · Cited by 146
Self-citationDiversity of actions of GnRHs mediated by ligand-induced selective signaling
Millar, R. P., Pawson, A. J., Morgan, K., Rissman, E. F., & Lu, Z.-L. (2007) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.06.002 · Cited by 145
Introduction to Special Section on β-Arrestins
Lefkowitz, R. J. (2007) · Annual Review of Physiology · doi:10.1146/annurev.ph.69.013107.100021 · Cited by 145
Self-citationBone Response to Intermittent Parathyroid Hormone Is Altered in Mice Null for β-Arrestin2
Ferrari, S., Pierroz, D. D., Glatt, V., Goddard, D. S., Bianchi, E. N., Lin, F., Manen, D., & Bouxsein, M. (2005) · Endocrinology · doi:10.1210/en.2004-1282 · Cited by 143
Chung, S., Funakoshi, T., & Civelli, O. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707606 · Cited by 143
Critical regulation of CD4+ T cell survival and autoimmunity by β-arrestin 1
Shi, Y., Feng, Y., Kang, J., Liu, C., Li, Z., Li, D., Cao, W., Qiu, J., Guo, Z., Bi, E., et al. (2007) · Nature Immunology · doi:10.1038/ni1489 · Cited by 141
Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors
Guigoni, C., Aubert, I., Li, Q., Gurevich, V. V., Benovic, J., Ferry, S., Mach, U., Stark, H., Leriche, L., Håkansson, K., et al. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.11.005 · Cited by 141
The oxytocin receptor antagonist atosiban inhibits cell growth via a “biased agonist” mechanism
Reversi, A., Rimoldi, V., Marrocco, T., Cassoni, P., Bussolati, G., Parenti, M., & Chini, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409945200 · Cited by 139
Jørgensen, R., Kubale, V., Vrecl, M., Schwartz, T. W., & Elling, C. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120006 · Cited by 130
Gurwitz, D., Haring, R., Heldman, E., Fraser, C. M., Manor, D., & Fisher, A. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90220-8 · Cited by 129
DeFea, K. (2006) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154804 · Cited by 129
Cussac, D., Boutet-Robinet, E. A., Ailhaud, M., Newman‐Tancredi, A., Martel, J., Danty, N., & Rauly‐Lestienne, I. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.07.040 · Cited by 124
Co‐receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands
Simmons, G., Reeves, J. D., Hibbitts, S. J., Stine, J. T., Gray, P. W., Proudfoot, A. E. I., & Clapham, P. R. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17719.x · Cited by 123
Mottola, D. M., Kilts, J. D., Lewis, M. M., Connery, H. S., Walker, Q. D., Jones, S. R., Booth, R. G., Hyslop, D. K., Piercey, M., Wightman, R. M., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1166 · Cited by 123
β-Arrestin 2-Dependent Angiotensin II Type 1A Receptor-Mediated Pathway of Chemotaxis
Hunton, D. L., Barnes, W. G., Kim, J., Ren, X.-R., Violin, J. D., Reiter, É., Milligan, G., Patel, D. D., & Lefkowitz, R. J. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006270 · Cited by 123
Self-citationAbramson, M. J., Walters, J. A., & Walters, E. H. (2003) · American Journal of Respiratory Medicine · doi:10.1007/bf03256657 · Cited by 122
Kim, J., Zhang, L., Peppel, K., Wu, J., Zidar, D. A., Brian, L., DeWire, S. M., Exum, S. T., Lefkowitz, R. J., & Freedman, N. J. (2008) · Circulation Research · doi:10.1161/circresaha.108.172338 · Cited by 119
Self-citationRamachandran, R., Mihara, K., Mathur, M., Rochdi, M. D., Bouvier, M., DeFea, K., & Hollenberg, M. D. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.055509 · Cited by 119
Identification of Allosteric Peptide Agonists of CXCR4
Sachpatzidis, A., Benton, B. K., Manfredi, J. P., Wang, H., Hamilton, A. D., Dohlman, H. G., & Lolis, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m204667200 · Cited by 117
Vilardaga, J., Frank, M., Krasel, C., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011495200 · Cited by 113
Lymperopoulos, A., Rengo, G., Zincarelli, C., Kim, J., Soltys, S., & Koch, W. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811706106 · Cited by 113
Kim, J., Ahn, S., Rajagopal, K., & Lefkowitz, R. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808176200 · Cited by 111
Self-citationPhysiological and pharmacological implications of beta-arrestin regulation
Schmid, C. L., & Bohn, L. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.11.005 · Cited by 111
Functional Selectivity of Natural and Synthetic Prostaglandin EP4 Receptor Ligands
Leduc, M., Breton, B., Galès, C., Gouill, C. L., Bouvier, M., Chemtob, S., & Heveker, N. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.156398 · Cited by 111
Berry, S. A., Shah, M. C., Khan, N., & Roth, B. L. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09230-2 · Cited by 110
Differential Signaling of the Endogenous Agonists at the β2-Adrenergic Receptor
Reiner, S., Ambrosio, M., Hoffmann, C., & Lohse, M. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.175604 · Cited by 108
Wu, D., Yang, L., Goschke, A., Stumm, R. K., Brandenburg, L., Liang, Y.-J., Höllt, V., & Koch, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05063.x · Cited by 107
Bézard, E., Gross, C. E., Li, Q., Gurevich, V. V., Benovic, J., & Gurevich, E. V. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.10.005 · Cited by 105
β-Arrestin-mediated Signaling Regulates Protein Synthesis
DeWire, S. M., Kim, J., Whalen, E. J., Ahn, S., Chen, M., & Lefkowitz, R. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710515200 · Cited by 105
Self-citationJean‐Alphonse, F., Perkovska, S., Frantz, M., Durroux, T., Méjean, C., Morin, D., Loison, S., Bonnet, D., Hibert, M., Mouillac, B., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008121289 · Cited by 105
Semple, G., Skinner, P. J., Gharbaoui, T., Shin, Y., Jung, J., Cherrier, M. C., Webb, P. J., Tamura, S. Y., Boatman, P. D., Sage, C. R., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800258p · Cited by 104
Morphine-like Opiates Selectively Antagonize Receptor-Arrestin Interactions
Molinari, P., Vezzi, V., Sbraccia, M., Grò, M. C., Riitano, D., Ambrosio, C., Casella, I., & Costa, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.059410 · Cited by 104
Watson, C., Chen, G., Irving, P. E., Way, J. M., Chen, W.-J., & Kenakin, T. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1230 · Cited by 103
Vilardaga, J., Krasel, C., Chauvin, S., Bambino, T., Lohse, M. J., & Nissenson, R. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110433200 · Cited by 101
An essential function for β-arrestin 2 in the inhibitory signaling of natural killer cells
Yu, M., Su, L., Zou, L., Liu, Y., Wu, N., Kong, L., Zhuang, Z., Sun, L., Liu, H., Hu, J., et al. (2008) · Nature Immunology · doi:10.1038/ni.1635 · Cited by 100
Niacin in cardiovascular prevention: mechanisms, efficacy, and safety
Guyton, J. R. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282364add · Cited by 100
Divergent Behavioral Roles of Angiotensin Receptor Intracellular Signaling Cascades
Daniels, D., Yee, D. K., Faulconbridge, L. F., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0774 · Cited by 100
Mathiesen, J. M., Ulven, T., Martini, L., Gerlach, L. O., Heinemann, Á., & Kostenis, E. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010520 · Cited by 100
Werry, T. D., Gregory, K. J., Sexton, P. M., & Christopoulos, A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03161.x · Cited by 99
Arrestin 3 Mediates Endocytosis of CCR7 following Ligation of CCL19 but Not CCL21
Byers, M. A., Calloway, P. A., Shannon, L., Cunningham, H. D., Smith, S. E., Li, F., Fassold, B. C., & Vines, C. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4723 · Cited by 98
Bisello, A., Chorev, M., Rosenblatt, M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202544200 · Cited by 98
Nicotinic Acid Receptor Agonists Differentially Activate Downstream Effectors
Richman, J. G., Kanemitsu-Parks, M., Gaidarov, I., Cameron, J. S., Griffin, P. S., Zheng, H., Guerra, N. C., Cham, L., Maciejewski-Lenoir, D., Behan, D. P., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701866200 · Cited by 97
Terwilliger, R. Z., Ortiz, J., Guitart, X., & Nestler, E. J. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63051983.x · Cited by 95
Altered CXCR2 Signaling in β-Arrestin-2-Deficient Mouse Models
Su, Y., Raghuwanshi, S. K., Yu, Y., Nanney, L. B., Richardson, R. M., & Richmond, A. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5396 · Cited by 94
Gettys, T. W., Fields, T. A., & Raymond, J. R. (1994) · Biochemistry · doi:10.1021/bi00180a024 · Cited by 94
Hall, D. A., Beresford, I. J. M., Browning, C., & Giles, H. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702329 · Cited by 90
Lee, D. K., Ferguson, S. S. G., George, S. R., & O’Dowd, B. F. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.151 · Cited by 89
Blanpain, C., Libert, F., Vassart, G., & Parmentier, M. (2002) · PubMed · Cited by 89
Deshpande, D. A., Theriot, B. S., Penn, R. B., & Walker, J. K. L. (2008) · The FASEB Journal · doi:10.1096/fj.07-102459 · Cited by 87
Recovery From Bronchoconstriction and Bronchodilator Tolerance
Haney, S. D., & Hancox, R. J. (2006) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:31:2:181 · Cited by 85
Kilts, J. D., Connery, H. S., Arrington, E. G., Lewis, M. M., Lawler, C. P., Oxford, G. S., O’Malley, K. L., Todd, R. D., Blake, B. L., Nichols, D. E., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1179 · Cited by 83
Shen, H. C., Ding, F., Deng, Q., Wilsie, L. C., Krsmanovic, M. L., Taggart, A. K. P., Carballo‐Jane, E., Ren, N., Cai, T., Wu, T.-J., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900151e · Cited by 82
Aplin, M., Christensen, G. L., Schneider, M., Heydorn, A., Gammeltoft, S., Kjølbye, A. L., Sheikh, S. P., & Hansen, J. L. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00064.x · Cited by 78
Apparent Loss-of-Function Mutant GPCRs Revealed as Constitutively Desensitized Receptors
Wilbanks, A. M., Laporte, S. A., Bohn, L., Barak, L. S., & Caron, M. G. (2002) · Biochemistry · doi:10.1021/bi020275m · Cited by 78
Identification of βArrestin2 as a corepressor of androgen receptor signaling in prostate cancer
Lakshmikanthan, V., Zou, L., Kim, J. I., Michal, A. M., Nie, Z., Messias, N. C., Benovic, J., & Daaka, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900258106 · Cited by 78
Klewe, I. V., Nielsen, S. M., TARPO, L., Urizar, E. T., Dipace, C., Javitch, J. A., Gether, U., Egebjerg, J., & Christensen, K. V. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.03.015 · Cited by 77
Bouxsein, M., Pierroz, D. D., Glatt, V., Goddard, D. S., Cavat, F., Rizzoli, R., & Ferrari, S. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041204 · Cited by 77
Chun, K., Lao, H.-C., Trempus, C. S., Okada, M., & Langenbach, R. I. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp168 · Cited by 77
Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia
Бычков, Э. Р., Gurevich, V. V., Joyce, J. N., Benovic, J., & Gurevich, E. V. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.10.012 · Cited by 76
Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades
Chen, J., Rusnak, M., Lombroso, P. J., & Sidhu, A. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06590.x · Cited by 75
Phaneuf, S., Asbóth, G., MacKenzie, I. Z., Melin, P., & Bernal, A. L. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(94)90414-6 · Cited by 74
Depletion of β-Arrestin-2 Promotes Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer
Raghuwanshi, S. K., Nasser, M. W., Chen, X. L., Strieter, R. M., & Richardson, R. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5699 · Cited by 72
Extended-release niacin for modifying the lipoprotein profile
Guyton, J. R. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.6.1385 · Cited by 71
Ryman-Rasmussen, J. P., Nichols, D. E., & Mailman, R. B. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012153 · Cited by 69
Rapid Desensitization of the Serotonin2C Receptor System: Effector Pathway and Agonist Dependence
Stout, B. D., Clarke, W. P., & Berg, K. A. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.3.957 · Cited by 67
Yun, S. P., Ryu, J. M., Jang, M. W., & Han, H. J. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22366 · Cited by 67
Sensitivity to Δ9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2−/− mice
Breivogel, C. S., Lambert, J. M., Gerfin, S., Huffman, J. W., & Razdan, R. K. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328308f1e6 · Cited by 66
Beta‐arrestin 2 negatively regulates sepsis‐induced inflammation
Fan, H., Bitto, A., Zingarelli, B., Luttrell, L. M., Borg, K. T., Halushka, P. V., & Cook, J. A. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03185.x · Cited by 66
Aplin, M., Christensen, G. L., Schneider, M., Heydorn, A., Gammeltoft, S., Kjølbye, A. L., Sheikh, S. P., & Hansen, J. L. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00063.x · Cited by 65
Differential regulation of β-arrestin 1 and β-arrestin 2 gene expression in rat brain by morphine
Fan, X.-L., Zhang, J. S., Zhang, X., Yue, W., & Ma, L. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00930-2 · Cited by 64
Mechanisms of Ligand-Induced Desensitization of the 5-Hydroxytryptamine2A Receptor
Hanley, N. R. S., & Hensler, J. G. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.468 · Cited by 64
Kizaki, T., Izawa, T., Sakurai, T., Haga, S., Taniguchi, N., Tajiri, H., Watanabe, K., Day, N. K. B., Toba, K., & Ohno, H. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02781.x · Cited by 61
Toll-like receptors differentially regulate GPCR kinases and arrestins in primary macrophages
Loniewski, K. J., Shi, Y., Pestka, J. J., & Parameswaran, N. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2007.11.012 · Cited by 60
Regulation of lipopolysaccharide‐induced inflammatory response and endotoxemia by β‐arrestins
Porter, K. J., Gonipeta, B., Parvataneni, S., Appledorn, D. M., Patial, S., Sharma, D., Gangur, V., Amalfitano, A., & Parameswaran, N. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22289 · Cited by 58
Mo, W., Zhang, L., Yang, G., Zhai, J., Hu, Z., Chen, Y., Chen, X., Hui, L., Huang, R., & Hu, G. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.06.017 · Cited by 57
Ahmed, M. R., Gurevich, V. V., Dalby, K. N., Benovic, J., & Gurevich, E. V. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131987 · Cited by 57
Zhang, J., Ferguson, S. S. G., Law, P., Barak, L. S., & Caron, M. G. (1999) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899909036653 · Cited by 57
Li, Y.-T., Liu, X., Liu, C., Kang, J.-H., Yang, J.-Y., Pei, G., & Wu, C.-F. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10030954 · Cited by 55
MacKinnon, A. C., Waters, C. M., Jodrell, D. I., Haslett, C., & Sethi, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009772200 · Cited by 54
Hollingsworth, J. W., Theriot, B. S., Li, Z., Lawson, B. L., Sunday, M. E., Schwartz, D. A., & Walker, J. K. L. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0198oc · Cited by 53
Ryman-Rasmussen, J. P., Griffith, A. R., Oloff, S., Vaidehi, N., Brown, J. T., Goddard, W. A., & Mailman, R. B. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.08.028 · Cited by 52
Fan, X., Zhang, J., Zhang, X., Yue, W., & Ma, L. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00147-8 · Cited by 51
Receptor-mediated binding and uptake of GnRH agonist and antagonist by pituitary cells
Jennes, L., Stumpf, W. E., & Conn, P. M. (1984) · Peptides · doi:10.1016/0196-9781(84)90279-1 · Cited by 51
Morphine promotes apoptosis via TLR2, and this is negatively regulated by β-arrestin 2
Li, Y., Sun, X., Zhang, Y., Huang, J., Hanley, G., Ferslew, K. E., Peng, Y., & Yin, D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.001 · Cited by 50
Castro, M., Dicker, F., Vilardaga, J., Krasel, C., Bernhardt, M., & Lohse, M. J. (2002) · Endocrinology · doi:10.1210/en.2002-220232 · Cited by 49
Li, J., Zhang, F., Jin, X.-L., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045559 · Cited by 49
Tsutsui, S., Vergote, D., Shariat, N., Warren, K. G., Ferguson, S. S. G., & Power, C. (2007) · The FASEB Journal · doi:10.1096/fj.07-9002com · Cited by 48
Kočan, M., See, H. B., Sampaio, N. G., Eidne, K. A., Feldman, B. J., & Pfleger, K. D. G. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0321 · Cited by 48
Selective activation of G alpha i mediated signalling of S1P3 by FTY720-phosphate
Sensken, S.-C., Stäubert, C., Keul, P., Levkau, B., Schöneberg, T., & Gräler, M. H. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.01.019 · Cited by 48
Zou, L., Yang, R., Chai, J., & Pei, G. (2007) · The FASEB Journal · doi:10.1096/fj.07-9046com · Cited by 47
Opioid receptor signaling: relevance for gastrointestinal therapy
Bohn, L., & Raehal, K. M. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.06.007 · Cited by 47
Modulation of voluntary ethanol consumption by beta‐arrestin 2
Björk, K., Rimondini, R., Hansson, A. C., Terasmaa, A., Hyytiä, P., Heilig, M. A., & Sommer, W. H. (2008) · The FASEB Journal · doi:10.1096/fj.07-102442 · Cited by 46
Cited by
Structure-Function of the G Protein–Coupled Receptor Superfamily
Katritch, V., Cherezov, V., & Stevens, R. C. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032112-135923 · Cited by 1,054
The delivery of therapeutic oligonucleotides
Juliano, R. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw236 · Cited by 854
Biased signalling: from simple switches to allosteric microprocessors
Smith, J. S., Lefkowitz, R. J., & Rajagopal, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.229 · Cited by 738
Self-citationSex differences in stress-related psychiatric disorders: neurobiological perspectives
Bangasser, D. A., & Valentino, R. J. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.03.008 · Cited by 737
β-arrestin-mediated receptor trafficking and signal transduction
Shenoy, S. K., & Lefkowitz, R. J. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.05.002 · Cited by 712
Self-citation
Metadata
- Authors
- Whalen, E. J., Rajagopal, S., & Lefkowitz, R. J.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 17
- Issue
- 3
- Pages
- 126-139
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2080192851
- Cited by
- 510
- References
- 222
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.